Interferon-alpha: a therapeutic target in systemic lupus erythematosus
about
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisFcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) ExpressionMxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohortInterferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil TreatmentType I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisInterferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection.Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.Type I interferon in organ-targeted autoimmune and inflammatory diseases.Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9.IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation.Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS.
P2860
Q28251763-60B8CB07-5F21-4BF6-AB7E-57A1A442589CQ30698666-82C552A6-3603-4682-8C18-D29AF80A1898Q33659118-E0DED287-3D25-4D15-9EDF-A71B7C631B0BQ33900485-533A9E44-CBE3-49AB-8F26-5557B02E8967Q34161393-EC5BA46D-0687-4086-A7E1-19B3773ECA52Q35236547-16E82599-6DAD-4A55-A57C-C2687DC1CA26Q35456519-C8EF20DE-FD96-4F38-A945-F8377E853672Q36088634-D6C4A9A9-44FA-4545-B0FC-30483E6DF6F6Q36139902-DECCBBF1-0E4A-43F9-8A58-A7FFE6711019Q36183169-38A2D28E-D351-41A0-B691-5EBCFD64D075Q37389500-6BE384BA-7BB1-4B22-B25C-568F810BB245Q37513066-25133AA4-1713-409D-BDE1-A232A1A30D9CQ37634933-5DF7FD2C-8323-4F90-BF7B-E8A9C83919EFQ37838003-52BD3417-44E3-4BB9-B1AB-4E9140DB7F94Q37990026-E7B141BF-61EB-435D-BFF1-4D8D27DE9E66Q38747383-D936EA8A-85FD-4324-B20D-6D3D299C0961Q38840206-2FA3A9E1-8CDB-453D-8859-38E7721E4396Q39264755-D10E47D7-52B5-47C9-A0D9-004D02510A9CQ40559584-D3FBC5B6-1878-46EB-87C5-969052C610D1Q47806004-81FE2372-B0F4-495D-A507-11C735C7CB65Q49499785-673E6325-FDE3-4AD1-A279-0193353E5DB5Q49852055-7F3603C9-C485-4D19-B244-C36ED1247C0BQ49884872-52862D44-ABC3-4FAD-A60A-C55F9FB3A498Q50875976-3B26B521-3267-48E9-9697-9DF64C7F3446
P2860
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@ast
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@en
type
label
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@ast
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@en
prefLabel
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@ast
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@en
P2860
P1476
Interferon-alpha: a therapeutic target in systemic lupus erythematosus
@en
P2093
Mary K Crow
P2860
P304
P356
10.1016/J.RDC.2009.12.008
P577
2010-02-01T00:00:00Z